Advertisement
Advertisement
September 12, 2022
Haemonetics Vascade Vascular Closure Product Portfolio Earns CE Mark
September 12, 2022—Haemonetics Corporation announced it has earned CE Mark certification for its Vascade vascular closure and Vascade MVP venous vascular closure systems.
The company advised that the CE Mark will allow the company to engage in the next steps of country-specific entrance of both products into the European Union and forms the basis for entry into other geographies that recognize CE Mark.
According to Haemonetics, the Vascade system is designed for small-bore femoral arterial and venous closure, generally used in interventional cardiology and peripheral vascular procedures.
The Vascade MVP system is designed for midbore multiaccess femoral venous closure, generally used in electrophysiology procedures. Vascade MVP is also FDA approved for use following cardiac ablation procedures requiring two or more access sites within the same limb.
The Vascade and Vascade MVP devices include the company’s collapsible disc technology and a resorbable collagen patch to achieve hemostasis. Both are designed to save time for hospital staff, while helping patients reach hemostasis faster with fewer complications on average, stated the company.
Advertisement
Advertisement
